Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

21. Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection

Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection 29527279 2018 11 14 1985-207X 12 3 2017 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia Malays Fam Physician Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection. 33-36 Urinary tract infection (UTI) is one of the most common presentations in general practice and, in most instances (...) , occurs in a single episode and is easily treated with a course of anti-microbial therapy. In the case of recurrent urinary tract infections, it is important to consider evaluation for any underlying causes. We report the case of a 32 year old female who had recurrent UTIs; this was a case of recurrent UTI secondary to xanthogranulomatous pyelonephritis from renal stones with resultant reno-colic fistula formation. Onn L V LV Department of Medicine, RIPAS Hospital, Bandar Seri Begawan BA, Brunei

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia2017 Full Text: Link to full Text with Trip Pro

22. Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis

Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis

Medical Services Advisory Committee2017

23. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial.

Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. Objective To investigate whether symptomatic treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is non-inferior to antibiotics in the treatment of uncomplicated lower urinary tract infection (UTI) in women, thus offering an opportunity to reduce antibiotic use in ambulatory care.Design Randomised, double blind, non-inferiority trial.Setting 17 general

BMJ2017

24. Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection

Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection 29134108 2018 11 29 2055-5008 3 2017 NPJ biofilms and microbiomes NPJ Biofilms Microbiomes Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection. 28 10.1038/s41522-017-0036-z Enterococcus faecalis is a leading causative agent of catheter-associated (...) urinary tract infection (CAUTI), the most common hospital-acquired infection. Its ability to grow and form catheter biofilm is dependent upon host fibrinogen (Fg). Examined here are how bacterial and host proteases interact with Fg and contribute to virulence. Analysis of mutants affecting the two major secreted proteases of E. faecalis OG1RF (GelE, SprE) revealed that while the loss of either had no effect on virulence in a murine CAUTI model or for formation of Fg-dependent biofilm in urine

NPJ biofilms and microbiomes2017 Full Text: Link to full Text with Trip Pro

25. Urinary Tract Infection.

Urinary Tract Infection. Urinary tract infections (UTIs) are common in both inpatient and outpatient settings. This article provides an evidence-based, clinically relevant overview of management of UTIs, including screening, diagnosis, treatment, and prevention. Conditions covered include acute cystitis (both uncomplicated and complicated), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.

Annals of Internal Medicine2017

26. Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinary tract infections

Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinary tract infections VABOMERE (meropenem and vaborbactam) Powder for Injection U.S. Department of Health and Human Services Search FDA Submit search VABOMERE (meropenem and vaborbactam) Powder for Injection VABOMERE Company: Rempex Pharmaceuticals, Inc. Application No.: 209776 Approval Date: 08/29/2017 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF

FDA - Drug Approval Package2017

27. The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long-term antibiotic therapy

The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long-term antibiotic therapy "The efficacy of D-mannose in the prevention of recurrent urinary tract" by Kristine Stompro > > > > Title Author Date of Graduation Summer 8-12-2017 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background: Recurrent urinary tract infections are a significant problem in women and the current mainstay (...) of prophylactic therapy is long-term antibiotic use. Based on recent studies, there is a possible natural remedy that could reduce the use of antibiotics for preventative medicine in recurrent urinary tract infections. This would decrease the chance of antibiotic resistance and the side effects of the antibiotics to the user. Methods: An exhaustive search of CINAHL, MEDLINE-Ovid, MEDLINE-PubMed, and Web of Science with the search terms “D-mannose” and “recurrent urinary tract infection” was performed

Pacific University EBM Capstone Project2017

28. NSAIDs as treatment for uncomplicated urinary tract infections

NSAIDs as treatment for uncomplicated urinary tract infections NSAIDs as treatment for uncomplicated urinary tract infections » Morsels of Evidence Search Evidence based medicine for general practitioners « Jun 09 NSAIDs as treatment for uncomplicated urinary tract infections Categories: , , by Journal reference: Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled (...) on the GPs Down Under forum that discussed the surprising (to me) concept that NSAIDs (non-steroidal anti-inflammatory drugs) could be used rather than antibiotics. What is the evidence for this therapy? Clinical question What is the effect of oral NSAIDs on symptoms and cure of uncomplicated UTIs, as compared to antibiotics? What does the research evidence say? Step 1: The Cochrane Library There are several systematic reviews of antibiotics as treatment for urinary tract infections (UTIs) [1

Morsels of Evidence2017

29. NSAIDs as treatment for uncomplicated urinary tract infections

NSAIDs as treatment for uncomplicated urinary tract infections NSAIDs as treatment for uncomplicated urinary tract infections – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2017\/06\/mo2017-5.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Jun 09 2017 NSAIDs as treatment for uncomplicated (...) urinary tract infections By in , , Journal reference: Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. Bmj 2015 Dec 23;351:h6544. Link: Published: December 2015 Evidence cookie says… NSAIDs should not be recommended as a first line treatment for uncomplicated UTIs in women compared with women who received empirical antibiotics, those who received regular

Morsels of Evidence2017

30. Does this woman have an acute uncomplicated urinary tract infection?

Does this woman have an acute uncomplicated urinary tract infection? CONTEXT: Symptoms suggestive of acute urinary tract infection (UTI) constitute one of the most common reasons for women to visit clinicians. Although the clinical encounter typically involves taking a history and performing a physical examination, the diagnostic accuracy of the clinical assessment for UTI remains uncertain. OBJECTIVE: To review the accuracy and precision of history taking and physical examination (...) present with 1 or more symptoms of UTI, the probability of infection is approximately 50%. Specific combinations of symptoms (eg, dysuria and frequency without vaginal discharge or irritation) raise the probability of UTI to more than 90%, effectively ruling in the diagnosis based on history alone. In contrast, history taking, physical examination, and dipstick urinalysis are not able to reliably lower the posttest probability of disease to a level where a UTI can be ruled out when a patient presents

JAMA2017

32. Prevention of catheter associated urinary tract infections

Prevention of catheter associated urinary tract infections Prevention of catheter associated urinary tract infections - NIPH Selected items added to basket Close Vis søkefelt How can we help you today? Search for: Søk Menu • • Prevention of catheter associated urinary tract infections Søk i Folkehelsa.no Search for: Søk Infectious diseases & Vaccines Close Mental & Physical health Close Environment & Lifestyle Close Health in Norway Close Quality & Knowledge Close Research & Access to data (...) interventions may reduce the number of catheter as-sociated urinary tract infections (evidence level very low and low quality). Removal of urinary catheters as soon as possible after surgery may reduce the number of urinary tract infections (evidence level low quality). When inserting or removing urinary catheters there is no conclusive evi-dence regarding the use of sterile technique compared to clean technique. American guidelines recommend health workers in hospital or acute set-tings to use sterile

The Norwegian Knowledge Centre for the Health Services2017